Sales from controversial drug discount program rose to $54 billion last year; Generic makers fall short when providing access to low- and middle-income countries
Taking stock of the drug industry, from the lab to the medicine chest September 29, 2023 Check out STAT+ Sponsored By By Ed Silverman Phar...Read More